Cited by 625Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment ResearchCancer-related cognitive impairment studies

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study

Aarsland, D., Brønnick, K., Larsen, J. P., Tysnes, O. B., Alves, G.·2009·Neurology

DOI 10.1212/01.wnl.0000338632.00552.cb

Open this paper in CoChat — free account

Abstract

BACKGROUND: Little is known regarding the cognitive impairment in subjects with early, drug-naïve Parkinson disease (PD). The aim of this study was to explore the proportion with mild cognitive impairment (MCI) and subtypes in an incidence cohort of untreated PD in Southern and Western Norway. METHODS: A total of 196 non-demented, drug-naive patients who were recruited after an extensive search of all new cases of PD in the area and 201 healthy control subjects completed a battery of neuropsychological tests of verbal memory, visuospatial, and attentional-executive functioning. Subjects were classified as MCI if the age- and education-corrected z-score was falling 1.5 standard deviations below the mean for at least one of the cognitive domains. RESULTS: The PD group was more impaired on all neuropsychological tests than controls, but the effect sizes were small. The largest effect size was found for verbal memory. A total of 18.9% of the patients with PD were classified as MCI, with a relative risk of 2.1 (1.2-3.6) in PD compared to the control group. Patients with PD with and without MCI did not differ significantly regarding demographic and motor features. Among PD-MCI patients, nearly two-thirds had a non-amnestic MCI subtype, and one third had an amnestic MCI subtype. CONCLUSIONS: The findings demonstrate a twofold increase in the proportion with cognitive impairment in subjects with early, untreated Parkinson disease (PD) compared to controls. This has implications for diagnosis and management of PD. AD = Alzheimer disease; aMCI-MD = amnestic multiple-domain MCI; aMCI-SD = amnestic single-domain MCI; CVLT-2 = California Verbal Learning Test II; IQCode = Informant Questionnaire on Cognitive decline in the elderly; MADRS = Montgomery and Aasberg Depression Rating Scale; MCI = mild cognitive impairment; MMSE = Mini-Mental State Examination; naMCI-MD = non-amnestic multiple-domain MCI; naMCI-SD = non-amnestic single-domain MCI; PD = Parkinson disease; RR = relative risks; UPDRS = Unified Parkinson's Disease Rating Scale; VOSP = Visual Object and Space Perception Battery.

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000338632.00552.cb

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Mild cognitive impairment – Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment.
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Self-citation
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
Dubois, B., Burn, D. J., Goetz, C. G., Aarsland, D., Brown, R. G., Broe, G. A., Dickson, D. W., Duyckaerts, C. J., Cummings, J., Gauthier, S. G., et al. (2007) · Movement Disorders · doi:10.1002/mds.21844 · Cited by 1,099
Self-citation
Cognitive profile of patients with newly diagnosed Parkinson disease
Muslimović, D., Post, B., Speelman, J. D., & Schmand, B. (2005) · Neurology · doi:10.1212/01.wnl.0000180516.69442.95 · Cited by 1,007
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams‐Gray, C. H., Foltynie, T., Brayne, C., Robbins, T. W., & Barker, R. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 935
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): a review
Jorm, A. F. (2004) · International Psychogeriatrics · doi:10.1017/s1041610204000390 · Cited by 823
Depression rating scales in Parkinson's disease: Critique and recommendations
Schrag, A. E., Barone, P., Brown, R. G., Leentjens, A. F. G., McDonald, W. M., STARKSTEIN, S. E., Weintraub, D. A., Poewe, W. H., Rascol, O., Sampaio, C., et al. (2007) · Movement Disorders · doi:10.1002/mds.21333 · Cited by 690

Show all 25 references

Research works printed but not linked: 2

Delis DC Kramer JHEK Ober BA. CVLT-II. California Verbal Learning Test. Second Edition. Adult Version. San Antonio TX: The Psychological Corporation: Harcourt Assessment Inc;
Emre M. Dementia associated with Parkinson’s disease. Lancet Neurol 2003;2:229–237.

Sorted by citations

Items 101–200 of 620

Cognitive Impairment and Dementia in Parkinson Disease
Goldman, J. G., & Sieg, E. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.01.001 · Cited by 116
Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
Bohnen, N. I., Kotagal, V., Müller, M. L. T. M., Koeppe, R. A., Scott, P. J. H., Albin, R. L., Frey, K. A., & Petrou, M. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.10.008 · Cited by 114
What About the Role of Virtual Reality in Parkinson Disease’s Cognitive Rehabilitation? Preliminary Findings From a Randomized Clinical Trial
Maggio, M. G., Cola, M. C. D., Latella, D., Maresca, G., Finocchiaro, C., Rosa, G. L., Cimino, V., Sorbera, C., Bramanti, P., Luca, R. D., et al. (2018) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988718807973 · Cited by 114
Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease
Liu, R., Umbach, D. M., Peddada, S. D., Xu, Z., Tröster, A. I., Huang, X., & Chen, H. (2015) · Neurology · doi:10.1212/wnl.0000000000001609 · Cited by 115
Clinical differences among mild cognitive impairment subtypes in Parkinson's disease
Goldman, J. G., Weis, H., Stebbins, G. T., Bernard, B. A., & Goetz, C. G. (2012) · Movement Disorders · doi:10.1002/mds.25062 · Cited by 110
Parkinson's disease compromises the appraisal of action meanings evoked by naturalistic texts
García, A. M., Bocanegra, Y., Herrera, E., Moreno, L., Arroyave, J. A. C., Baena, A. Y., Lopera, F. J., Pineda, D. A., Melloni, M., Legaz, A., et al. (2017) · Cortex · doi:10.1016/j.cortex.2017.07.003 · Cited by 114
Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model
Hou, L., Sun, F., Huang, R., Sun, W., Zhang, D., & Wang, Q. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101134 · Cited by 112
Relationship between mild cognitive impairment and falls in older people with and without Parkinson's disease: 1-Year Prospective Cohort Study
Camicioli, R. M., & Majumdar, S. R. (2010) · Gait & Posture · doi:10.1016/j.gaitpost.2010.03.013 · Cited by 110
Antisaccades and executive dysfunction in early drug‐naive Parkinson's disease: The discovery study
Antoniades, C. A., Demeyere, N., Kennard, C., Humphreys, G. W., & Hu, M. T. (2015) · Movement Disorders · doi:10.1002/mds.26134 · Cited by 114
Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study
Kalbe, E., Rehberg, S., Heber, I. A., Kronenbuerger, M., Schulz, J. B., Storch, A., Linse, K., Schneider, C. B., Gräber, S., Liepelt‐Scarfone, I., et al. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-313838 · Cited by 106
Mild cognitive impairment and cognitive reserve in Parkinson’s disease
Poletti, M., Emre, M., & Bonuccelli, U. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.03.013 · Cited by 116
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings
Chahine, L. M., Weintraub, D. A., Hawkins, K. A., Siderowf, A. D., Eberly, S. W., Oakes, D., Seibyl, J. P., Stern, M. B., MAREK, K. L., Jennings, D. L., et al. (2015) · Movement Disorders · doi:10.1002/mds.26373 · Cited by 108
Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits
Lebedev, A. V., Westman, E., Simmons, A., Lebedeva, A., Siepel, F. J., Pereira, J. B., & Aarsland, D. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00045 · Cited by 100
Self-citation
Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited.
Brønnick, K., Norwegian ParkWest Study Group, Alves, G. W., Aarsland, D., Tysnes, O., & Larsen, J. P. (2010) · Neuropsychology · doi:10.1037/a0020857 · Cited by 108
Self-citation
Neuroimaging Markers of Motor and Nonmotor Features of Parkinson's Disease: An [18F]Fluorodeoxyglucose Positron Emission Computed Tomography Study
Huang, C. C., Ravdin, L., Nirenberg, M. J., Piboolnurak, P., Severt, L., Maniscalco, J. S., Sólnes, L. B., Dorfman, B. J., & Henchcliffe, C. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000345987 · Cited by 105
Cognitive‐nigrostriatal relationships in de novo, drug‐naïve Parkinson's disease patients: A [I‐123]FP‐CIT SPECT study
Nobili, F. M., Campus, C., Arnaldi, D., Carli, F. D., Cabassi, G., Brugnolo, A., Dessi, B., Morbelli, S. D., Sambuceti, G., Abbruzzese, G., et al. (2010) · Movement Disorders · doi:10.1002/mds.22899 · Cited by 99
Cognitive Change in Newly-Diagnosed Patients with Parkinson's Disease: A 5-Year Follow-up Study
Broeders, M., Velseboer, D. C., de Bie, R. M. A., Speelman, J. D., Muslimović, D., Post, B., de Haan, R. J., & Schmand, B. A. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617713000295 · Cited by 99
The range and nature of non-motor symptoms in drug-naive Parkinson’s disease patients: a state-of-the-art systematic review
Zis, P., Erro, R., Walton, C. C., Sauerbier, A., & Chaudhuri, К. R. (2015) · npj Parkinson s Disease · doi:10.1038/npjparkd.2015.13 · Cited by 98
Long-Term Dementia Risk in Parkinson Disease
Gallagher, J., Gochanour, C., Caspell‐Garcia, C., Dobkin, R. D., Aarsland, D., Alcalay, R. N., Barrett, M. J., Chahine, L. M., Chen‐Plotkin, A. S., Coffey, C. S., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209699 · Cited by 98
Self-citation
Measuring functional impact of cognitive impairment: Validation of the Parkinson's Disease Cognitive Functional Rating Scale
Kulisevsky, J., de Bobadilla, R. F., Pagonabarraga, J., Martínez‐Horta, S., Campolongo, A., García‐Sánchez, C., Pascual‐Sedano, B., Nogué, R. R., & Villa-Bonomo, C. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.05.007 · Cited by 101
Soluble TREM2 is elevated in Parkinson’s disease subgroups with increased CSF tau
Wilson, E. N., Swarovski, M. S., Linortner, P., Shahid, M., Zuckerman, A. J., Wang, Q., Channappa, D., Minhas, P. S., Mhatre, S. D., Plowey, E. D., et al. (2020) · Brain · doi:10.1093/brain/awaa021 · Cited by 99
Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine
dos Santos, J. R., Cunha, J. A., Dierschnabel, A. L., Campêlo, C. L. D. C., Leão, A. H. F. F., Silva, A. F., Engelberth, R. C. G. J., Izídio, G. S., Cavalcante, J. S., Abílio, V. C., et al. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.06.031 · Cited by 97
Apathy in drug-naïve patients with incident Parkinson’s disease: the Norwegian ParkWest study
Pedersen, K. F., Alves, G. W., Brønnick, K., Aarsland, D., Tysnes, O., & Larsen, J. P. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5297-x · Cited by 96
Self-citation
Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease
Post, B., Muslimović, D., van Geloven, N., Speelman, J. D., Schmand, B. A., de Haan, R. J., & on behalf of the CARPA‐study group (2011) · Movement Disorders · doi:10.1002/mds.23467 · Cited by 96
Biomarkers of cognitive decline in Parkinson's disease
Lin, C., & Wu, R. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.02.010 · Cited by 100
Theory of Mind in Parkinson's disease
Poletti, M., Enrici, I., Bonuccelli, U., & Adenzato, M. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.010 · Cited by 94
Predicting dementia development in Parkinson's disease using Bayesian network classifiers
Morales, D. A., Vives‐Gilabert, Y., Gómez‐Ansón, B., Bengoetxea, E., Larrañaga, P., Bielza, C., Pagonabarraga, J., Kulisevsky, J., Corcuera‐Solano, I., & Delfino, M. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.06.001 · Cited by 96
Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment
Goldman, J. G., Holden, S. K., Litvan, I., McKeith, I. G., Stebbins, G. T., & Taylor, J. (2018) · Movement Disorders · doi:10.1002/mds.27323 · Cited by 93
Mild Cognitive Impairment in Parkinson’s Disease—What Is It?
Weil, R. S., Costantini, A. A., & Schrag, A. E. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0823-9 · Cited by 94
Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease
Ibarretxe‐Bilbao, N., Junqué, C., Martı́, M. J., & TOLOSA, E. S. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.07.054 · Cited by 90
Timing variability and midfrontal ~4 Hz rhythms correlate with cognition in Parkinson’s disease
Singh, A. P., Cole, R. C., Espinoza, A. I., Evans, A., Cao, S., Cavanagh, J. F., & Narayanan, N. S. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00158-x · Cited by 90
Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's disease
Beyer, M. K., Brønnick, K., Hwang, K., Bergsland, N., Tysnes, O., Larsen, J. P., Thompson, P. M., Somme, J. H., & Apostolova, L. G. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303054 · Cited by 92
Self-citation
Neuropathology of prodromal Lewy body disease
Iranzo, Á., Gelpí, E., Tolosa, E. S., Molinuevo, J. L., Serradell, M., Gaig, C., & Santamaría, J. (2014) · Movement Disorders · doi:10.1002/mds.25825 · Cited by 89
Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease
Polito, C., Berti, V., Ramat, S., Vanzi, E., Cristofaro, M. T. D., Pellicanò, G., Mungai, F., Marini, P., Formiconi, A. R., Sorbi, S., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.004 · Cited by 91
Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism
Pappatà, S., Santangelo, G., Aarsland, D., Vicidomini, C., Longo, K., Brønnick, K., Amboni, M., Erro, R., Vitale, C., Caprio, M. G., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182315259 · Cited by 89
Self-citation
Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
Nicoletti, A. S. Q., Luca, A., Baschi, R., Cicero, C. E., Mostile, G., Davì, M., Pilati, L., Restivo, V., Zappia, M., & Monastero, R. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00021 · Cited by 88
Age and time course of long-term motor and nonmotor complications in Parkinson disease
Prange, S., Danaila, T., Laurencin, C., Caire, C., Météreau, É., Merle, H., Broussolle, E., Maucort‐Boulch, D., & Thobois, S. (2018) · Neurology · doi:10.1212/wnl.0000000000006737 · Cited by 87
Approach to Cognitive Impairment in Parkinson's Disease
Zhang, Q., Aldridge, G. M., Narayanan, N., Anderson, S. W., & Uc, E. Y. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00963-x · Cited by 87
Patterns of cortical thinning in nondemented Parkinson's disease patients
Uribe, C., Segura, B., Baggio, H. C., Abós, A., Martı́, M. J., Valldeoriola, F., Compta, Y., Bargalló, N., & Junqué, C. (2016) · Movement Disorders · doi:10.1002/mds.26590 · Cited by 86
Cognition in Parkinson's Disease
O’Callaghan, C., & Lewis, S. J. G. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.002 · Cited by 90
Caregiver distress associated with neuropsychiatric problems in patients with early Parkinson’s disease: the Norwegian ParkWest study
Leiknes, I., Tysnes, O., Aarsland, D., & Larsen, J. O. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01332.x · Cited by 85
Self-citation
Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease
Morley, J. F., Weintraub, D. A., Mamikonyan, E., Moberg, P. J., Siderowf, A. D., & Duda, J. E. (2011) · Movement Disorders · doi:10.1002/mds.23792 · Cited by 84
Personality traits in patients with Parkinson’s disease: assessment and clinical implications
Poletti, M., & Bonuccelli, U. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6302-8 · Cited by 83
Cognition and the course of prodromal Parkinson's disease
Weintraub, D. A., Chahine, L. M., Hawkins, K. A., Siderowf, A. D., Eberly, S. W., Oakes, D., Seibyl, J. P., Stern, M. B., MAREK, K. L., Jennings, D. L., et al. (2017) · Movement Disorders · doi:10.1002/mds.27189 · Cited by 83
Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status
Choi, S. H., Jung, T.-M., Lee, J. E., Lee, S., Sohn, Y. H., & Lee, P. H. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.015 · Cited by 83
White matter alterations in Parkinson’s disease with normal cognition precede grey matter atrophy
Rektor, I., Svátková, A., Vojtíšek, Ľ., Zikmundová, I., Vaníček, J., Király, A., & Szabó, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0187939 · Cited by 83
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
Weintraub, D. A., Caspell‐Garcia, C., Simuni, T., Cho, H. R., Coffey, C. S., Aarsland, D., Alcalay, R. N., Barrett, M. J., Chahine, L. M., Eberling, J. L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51022 · Cited by 82
Self-citation
Palliative care for Parkinson’s disease: A summary of the evidence and future directions
Richfield, E. W., Jones, E. J., & Alty, J. (2013) · Palliative Medicine · doi:10.1177/0269216313495287 · Cited by 82
Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis
Uribe, C., Segura, B., Baggio, H. C., Abós, A., García-Díaz, A. I., Campabadal, A., Martı́, M. J., Valldeoriola, F., Compta, Y., Tolosa, E. S., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.02.006 · Cited by 83
Parkinson's disease‐cognitive rating scale: Psychometrics for mild cognitive impairment
de Bobadilla, R. F., Pagonabarraga, J., Martínez‐Horta, S., Pascual‐Sedano, B., Campolongo, A., & Kulisevsky, J. (2013) · Movement Disorders · doi:10.1002/mds.25568 · Cited by 78
Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy
Mak, E., Zhou, J. H., Tan, L. C. S., Au, W., Sitoh, Y. Y., & Kandiah, N. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305805 · Cited by 76
Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson’s disease
Leverenz, J. B., Watson, G. S., Shofer, J., Zabetian, C. P., Zhang, J., & Montine, T. J. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.10.003 · Cited by 75
Mattis Dementia Rating Scale 2
Matteau, E., Dupré, N., Langlois, M., Jean, L., Thivierge, S. C., Provencher, P., & Simard, M. (2011) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317511412046 · Cited by 75
Regional vulnerability of hippocampal subfields and memory deficits in Parkinson's disease
Pereira, J. B., Junqué, C., Bartrés‐Faz, D., Ramírez‐Ruiz, B., Martı́, M. J., & TOLOSA, E. S. (2013) · Hippocampus · doi:10.1002/hipo.22131 · Cited by 77
White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease
Dalaker, T. O., Larsen, J. O., Dwyer, M. G., Aarsland, D., Beyer, M. K., Alves, G. W., Brønnick, K., Tysnes, O., & Zivadinov, R. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.020 · Cited by 74
Self-citation
Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease
Wood, L. D., Neumiller, J. J., Setter, S. M., & Dobbins, E. K. (2010) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2010.08.002 · Cited by 74
Parkinson disease-associated cognitive impairment
(2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00286-x · Cited by 73
Psychometric Properties of the Starkstein Apathy Scale in Patients With Early Untreated Parkinson Disease
Pedersen, K. F., Alves, G. W., Larsen, J. P., Tysnes, O., Møller, S. G., & Brønnick, K. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31823038f2 · Cited by 73
Self-citation
Ventricular enlargement and mild cognitive impairment in early Parkinson's disease
Dalaker, T. O., Zivadinov, R., Ramasamy, D. P., Beyer, M. K., Alves, G. W., Brønnick, K., Tysnes, O., Aarsland, D., & Larsen, J. O. (2010) · Movement Disorders · doi:10.1002/mds.23443 · Cited by 73
Self-citation
Dysfunction of the Default Mode Network in Drug-Naïve Parkinson’s Disease with Mild Cognitive Impairments: A Resting-State fMRI Study
Hou, Y., Yang, J., Luo, C., Song, W., Ou, R., Liu, W., Gong, Q., & Shang, H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00247 · Cited by 73
Differential Acute Effect of High-Intensity Interval or Continuous Moderate Exercise on Cognition in Individuals With Parkinson’s Disease
Fiorelli, C. M., Ciolac, E. G., Simieli, L., Silva, F. A., Fernandes, B., Christofoletti, G., & Barbieri, F. A. (2019) · Journal of Physical Activity and Health · doi:10.1123/jpah.2018-0189 · Cited by 72
Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson’s Disease
Murueta‐Goyena, A., Andikoetxea, A., Gómez‐Esteban, J. C., & Gabilondo, I. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01294 · Cited by 72
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders
Mollenhauer, B., Parnetti, L., Rektorová, I., Kramberger, M. G., Pikkarainen, M., Schulz‐Schaeffer, W., Aarsland, D., Svenningsson, P., Farotti, L., Verbeek, M. M., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13390 · Cited by 73
Self-citation
Compensatory neural mechanisms in cognitively unimpaired P arkinson disease
Poston, K. L., YorkWilliams, S. L., Zhang, K., Cai, W., Everling, D., Tayim, F. M., Llanes, S., & Menon, V. (2015) · Annals of Neurology · doi:10.1002/ana.24585 · Cited by 78
Palliative care and Parkinson's disease: Meeting summary and recommendations for clinical research
Kluger, B. M., Fox, S., Timmons, S., Katz, M., Galifianakis, N. B., Subramanian, I., Carter, J. H., Johnson, M. J., Richfield, E. W., Bekelman, D. B., et al. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.01.008 · Cited by 74
Virtual Reality Technology in Cognitive Rehabilitation Application: Bibliometric Analysis
He, D., Cao, S., Le, Y., Wang, M., Chen, Y., & Qian, B. (2022) · JMIR Serious Games · doi:10.2196/38315 · Cited by 72
Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment
Apostolova, L. G., Alves, G. W., Hwang, K., Babakchanian, S., Brønnick, K., Larsen, J. P., Thompson, P. M., Chou, Y., Tysnes, O., Vefring, H. K., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.014 · Cited by 74
Self-citation
Perspectives on recent advances in the understanding and treatment of Parkinson's disease
Schapira, A. H., Agid, Y., Barone, P., Jenner, P., Lemke, M. R., Poewe, W., Rascol, O., Reichmann, H., & Tolosa, E. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02793.x · Cited by 69
Contribution of language studies to the understanding of cognitive impairment and its progression over time in Parkinson’s disease
Auclair‐Ouellet, N., LIEBERMAN, P. H., & Monchi, O. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.014 · Cited by 74
Pacific Northwest Udall Center of Excellence Clinical Consortium: Study Design and Baseline Cohort Characteristics
Cholerton, B., Zabetian, C. P., Quinn, J. F., Chung, K. A., Peterson, A. L., Espay, A. J., Revilla, F. J., Devoto, J. L., Watson, G. S., Hu, S., et al. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130189 · Cited by 73
Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson's disease: A 4-year follow-up
García-Díaz, A. I., Segura, B., Baggio, H. C., Uribe, C., Campabadal, A., Abós, A., Martí, M. J., Valldeoriola, F., Compta, Y., Bargalló, N., et al. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.11.003 · Cited by 76
Can neuroimaging predict dementia in Parkinson’s disease?
Lanskey, J. H., McColgan, P., Schrag, A. E., Acosta‐Cabronero, J., Rees, G. E., Morris, H. R., & Weil, R. S. (2018) · Brain · doi:10.1093/brain/awy211 · Cited by 76
Cognitive impairment and dementia in patients with Parkinson disease.
Leverenz, J. B., Quinn, J. F., Zabetian, C. P., Zhang, J., Montine, K. S., & Montine, T. J. (2009) · PubMed · Cited by 69
Resting‐State Functional Brain Networks in Parkinson's Disease
Baggio, H. C., Segura, B., & Junqué, C. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12417 · Cited by 69
Explainable Artificial Intelligence of Multi-Level Stacking Ensemble for Detection of Alzheimer’s Disease Based on Particle Swarm Optimization and the Sub-Scores of Cognitive Biomarkers
AlMohimeed, A., Saad, R. M. A., Mostafa, S., El-Rashidy, N. M., Farrag, S., Gaballah, A., Elaziz, M. A., El–Sappagh, S., & Saleh, H. (2023) · IEEE Access · doi:10.1109/access.2023.3328331 · Cited by 67
Parkinson's Disease Mild Cognitive Impairment: Application and Validation of the Criteria
Geurtsen, G. J., Hoogland, J., Goldman, J. G., Schmand, B. A., Tröster, A. I., Burn, D. J., Litvan, I., & on behalf of the MDS Study group on the validation of PD-MCI criteria (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-130304 · Cited by 67
Gray matter correlations of cognition in incident Parkinson's disease
Dalaker, T. O., Zivadinov, R., Larsen, J. O., Beyer, M. K., Cox, J. L., Alves, G. W., Brønnick, K., Tysnes, O., Antulov, R., Dwyer, M. G., et al. (2010) · Movement Disorders · doi:10.1002/mds.22867 · Cited by 66
Self-citation
The source of the memory impairment in Parkinson's disease: Acquisition versus retrieval
Chiaravalloti, N. D., Ibarretxe‐Bilbao, N., DeLuca, J., Rusu, O., Peña, J., García‐Gorostiaga, I., & Ojeda, N. (2014) · Movement Disorders · doi:10.1002/mds.25842 · Cited by 66
Cerebrospinal fluid amyloid- and phenotypic heterogeneity in de novo Parkinson's disease
Alves, G. W., Pedersen, K. F., Bloem, B. R., Blennow, K., Zetterberg, H., Borm, G. F., Dalaker, T. O., Beyer, M. K., Aarsland, D., Andréasson, U., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303808 · Cited by 66
Self-citation
Network correlates of the cognitive response to levodopa in Parkinson disease
Mattis, P. J., Tang, C., Ma, Y., DHAWAN, V. M., & Eidelberg, D. (2011) · Neurology · doi:10.1212/wnl.0b013e31822c6224 · Cited by 66
Cerebral microbleeds in patients with Parkinson’s disease
Ham, J. H., Yi, H., Sunwoo, M. K., Hong, J. Y., Sohn, Y. H., & Lee, P. H. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7403-y · Cited by 65
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients
Erro, R., Santangelo, G., Picillo, M., Vitale, C., Amboni, M., Longo, K., di Polidoro, A. C., Pellecchia, M. T., Allocca, R., Rosa, A. D., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6407-0 · Cited by 66
Prevalence and timeline of nonmotor symptoms in idiopathic rapid eye movement sleep behavior disorder
Aguirre-Mardones, C., Iranzo, Á., Vilas, D., Serradell, M., Gaig, C., Santamaría, J., & TOLOSA, E. S. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7742-3 · Cited by 65
Unveiling relevant non-motor Parkinson's disease severity symptoms using a machine learning approach
Armañanzas, R., Bielza, C., Chaudhuri, К. R., Martínez‐Martín, P., & Larrañaga, P. (2013) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2013.04.002 · Cited by 65
Subcortical Volumes Differ in Parkinson’s Disease Motor Subtypes: New Insights into the Pathophysiology of Disparate Symptoms
Rosenberg‐Katz, K., Herman, T., Jacob, Y., Kliper, E., Giladi, N., & Hausdorff, J. M. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00356 · Cited by 65
Exercise as a therapeutic intervention for motor and non-motor symptoms in Parkinson’s disease: Evidence from rodent models
Crowley, E. K., Nolan, Y. M., & Sullivan, A. M. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.11.003 · Cited by 72
Decision making in de novo Parkinson's disease
Poletti, M., Frosini, D., Lucetti, C., Dotto, P. D., Ceravolo, R., & Bonuccelli, U. (2010) · Movement Disorders · doi:10.1002/mds.23098 · Cited by 64
Initial cognitive changes in Parkinson's disease
Weintraub, D. A., Tröster, A. I., Marras, C., & Stebbins, G. T. (2018) · Movement Disorders · doi:10.1002/mds.27330 · Cited by 69
Striatal and C ortical β‐ A myloidopathy and C ognition in P arkinson's D isease
Shah, N., Frey, K. A., Müller, M. L. T. M., Petrou, M., Kotagal, V., Koeppe, R. A., Scott, P. J. H., Albin, R. L., & Bohnen, N. I. (2015) · Movement Disorders · doi:10.1002/mds.26369 · Cited by 63
Evaluation of mild cognitive impairment subtypes in Parkinson's disease
Cholerton, B., Zabetian, C. P., Wan, J. Y., Montine, T. J., Quinn, J. F., Mata, I. F., Chung, K. A., Peterson, A. L., Espay, A. J., Revilla, F. J., et al. (2014) · Movement Disorders · doi:10.1002/mds.25875 · Cited by 63
SPECT Molecular Imaging in Parkinson's Disease
Wang, L., Zhang, Q., Li, H., & Zhang, H. (2012) · BioMed Research International · doi:10.1155/2012/412486 · Cited by 63
Natural Phenolic Compounds with Neuroprotective Effects
Tavan, M., Hanachi, P., Cádiz‐Gurrea, M. D. L. L., Segura‐Carretero, A., & Mirjalili, M. H. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04046-z · Cited by 66
Affective symptoms and cognitive functions in Parkinson's disease
Poletti, M., Rosa, A. D., & Bonuccelli, U. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.02.022 · Cited by 62
Cognitive correlates of cerebellar resting-state functional connectivity in Parkinson disease
Maiti, B., Koller, J. M., Snyder, A. Z., Tanenbaum, A., Norris, S. A., Campbell, M. C., & Perlmutter, J. S. (2019) · Neurology · doi:10.1212/wnl.0000000000008754 · Cited by 62
Parkinsonism and Related Disorders
Slow, E., & Lang, A. E. (2019) · DeckerMed Transitional Year Weekly Curriculum™ · doi:10.2310/tywc.1178 · Cited by 62
Behavioral and neuroimaging studies on language processing in Dutch speakers with Parkinson's disease
Colman, K. S. F. (2011) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 62
Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson’s disease
Inguanzo, A., Sala‐Llonch, R., Segura, B., Erostarbe, H., Abós, A., Campabadal, A., Uribe, C., Baggio, H. C., Compta, Y., Martı́, M. J., et al. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.11.010 · Cited by 61
Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease
Mak, E., Su, L., Williams, G. B., & O'Brien, J. T. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.05.013 · Cited by 61
Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging
Berendse, H. W., & Ponsen, M. M. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70774-6 · Cited by 60
Improved Sequence Learning with Subthalamic Nucleus Deep Brain Stimulation: Evidence for Treatment-Specific Network Modulation
Mure, H., Tang, C. C., Árgyelán, M., Ghilardi, M. F., Kaplitt, M. G., DHAWAN, V. M., & Eidelberg, D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4331-11.2012 · Cited by 59

Authors: Aarsland, D., Brønnick, K., Larsen, J. P., Tysnes, O. B., & Alves, G.
Affiliations: Stavanger University Hospital (NO)
From The Norwegian Centre for Movement Disorders (D.A., K.B., J.P.L., G.A.), Department of Neurology (J.P.L., G.A.), and Department of Psychiatry (D.A.), Stavanger University Hospital, Stavanger; Department of Neurology (O.B.T.), Haukeland University Hospital, Bergen; and School of Medicine (D.A., J.P.L., O.B.T.), University of Bergen, Norway.
ORCID: Aarsland, D.
Brønnick, K.
Tysnes, O. B.
Alves, G.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2009-03-31
Volume: 72
Issue: 13
Pages: 1121-1126
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/01.wnl.0000338632.00552.cb
OpenAlex: W2120049868
Cited by: 625
References: 25
Citations by year: 2026: 13 · 2025: 19 · 2024: 24 · 2023: 19 · 2022: 33 · 2021: 34 · 2020: 33 · 2019: 39 · 2018: 34 · 2017: 44 · 2016: 43 · 2015: 40 · 2014: 40 · 2013: 53 · 2012: 48
FWCI: 22.96
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords: Parkinson's disease, mild cognitive impairment, early-stage Parkinson's disease, amnestic MCI, non-amnestic MCI, verbal memory impairment, executive function, visuospatial ability, attention, prevalence of cognitive impairment
MeSH terms: Aged, Cognition Disorders, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neuropsychological Tests, Norway, Parkinson Disease, Prospective Studies, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks